Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
MOGENRY
product5 mentionslast seen Nov 5, 2026
Investigational optogenetic gene therapy for inherited retinal dystrophies, based on multi-characteristic opsin technology.
Relationships 16
- Nanoscope TherapeuticsdevelopsMOGENRY99% confidence5 sources
- MOGENRYapplies toretinitis pigmentosa treatment99% confidence5 sources
- MOGENRYdepends onmulti-characteristic opsin99% confidence4 sources
- MOGENRYapplies toStargardt disease treatment99% confidence4 sources
- MOGENRYapplies toinherited retinal dystrophies treatment99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesMOGENRY98% confidence3 sources
- MOGENRYapplies toinherited retinal dystrophies96% confidence1 source
- Pharmaceuticals and Medical Devices AgencyapprovesMOGENRY96% confidence3 sources
- MOGENRYapplies toinherited retinal dystrophy treatment95% confidence1 source
- MOGENRYdepends onmulti-characteristic opsin technology95% confidence1 source
- MOGENRYapplies todry age-related macular degeneration treatment90% confidence1 source
- European Medicines AgencyapprovesMOGENRY85% confidence1 source
- Pharmaceutical and Medical Device AgencyapprovesMOGENRY85% confidence1 source
- MOGENRYapplies togeographic atrophy treatment80% confidence1 source
- Food and Drug AdministrationapprovesMOGENRY75% confidence1 source
- MOGENRYapplies toLeber congenital amaurosis treatment75% confidence1 source
Relationship
MOGENRYapplies toinherited retinal dystrophies
96% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1